![](/img/cover-not-exists.png)
Two-year outcomes following percutaneous intervention: Beaumont Angiotensin converting enzyme Genotype and Endpoints Trial (the BAGET trial)
Kimberly A. Skelding, Laxmi Mehta, Demetris Demetriou, Domnita Crisan, Judith A. Boura, Cindy L. Grines, William W. O'NeillVolume:
39
Year:
2002
Language:
english
DOI:
10.1016/s0735-1097(02)80176-0
File:
PDF, 143 KB
english, 2002